Hongyi Hu

Dr. Hongyi Hu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2019 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
SZSongfeng Zou
Songfeng Zou
XMXueshuang Mei
Xueshuang Mei
WYWeiqiang Yang
Weiqiang Yang
RZRvfei Zhu
Rvfei Zhu
TYTao Yang
Tao Yang
HHHongyi Hu
Hongyi Hu

16 November 2021 in Oncology Letters
Verified
Journal Article
Open access
PDF file
YZYaqi Zhou
Yaqi Zhou
XMXueshuang Mei
Xueshuang Mei
YLYing Li
Ying Li
WYWeiqiang Yang
Weiqiang Yang
XSXi Su
Xi Su
HHHongyi Hu
Hongyi Hu
Cordycepin is an extract from the Cordyceps genus of ascomycete fungi. In the present study, the anticancer potential of cordycepin against nasopharyngeal carcinoma (NPC), and the potential underlying mechanisms, were investigated. Using Cell Counting Kit 8, wound‑healing and Transwell assays, cordycepin was found to reduce the viability and inhibit the migration of C666‑1 cells in a dose‑dependent manner. In addition, in colony formation assays, co‑treatment with cordycepin and cisplatin inhibited the proliferation of C666‑1 cells. Furthermore, RNA sequencing analysis identified 72 significantly differentially expressed genes and different signaling pathways that may be regulated by cordycepin. After treatment with cordycepin, the expression levels of ERK1/2, phosphorylated ERK1/2 and β‑catenin were significantly downregulated. Therefore, cordycepin may be a novel candidate for NPC treatment or a co‑treatment candidate with cisplatin in chemotherapy.

3 August 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
XLXiaochan Lu
Xiaochan Lu
NYNa Yin
Na Yin
CCChen Chen
Chen Chen
YZYaqi Zhou
Yaqi Zhou
LJLingchao Ji
Lingchao Ji
HHHongyi Hu
Hongyi Hu
Mangiferin(MGF) exhibits crucial biological roles, including antioxidant and anti-inflammatory functions. However, how to clearly elucidate the functioning mechanism of MGF for inhibiting cisplatin-induced hearing loss requires in-depth investigation. In this work, we aimed at gaining insight into how MGF functions as the protective agent against cisplatin-triggered ototoxicity using various assays. The variation for reactive oxygen species (ROS) concentrations was determined with MitoSOX-Red and 2',7'-Dichlorodihydrofluorescein diacetate staining (DCFH-DA). The protective function and corresponding mechanism of MGF in hair cell survival in the House Ear Institute-Organ of Corti (HEI-OC1) cell line were assessed using RNA sequencing (RNA-Seq). Our findings demonstrated that MGF significantly alleviated cisplatin-induced injury to hair cells in vitro, encompassing cell lines and cochlear explants, as well as in vivo models, including C57BL/6 J mice and zebrafish larvae. Mechanistic studies revealed that MGF reversed the increased accumulation of ROS and inhibited cell apoptosis through mitochondrial-mediated intrinsic pathway. Moreover, real-time quantitative polymerase chain reaction (RT-qPCR) and western blotting data indicated MGF protected against cisplatin-mediated ototoxicity via the mitogen-activated protein kinase pathway (MAPK). These findings demonstrated MGF has significant potential promise in combating cisplatin-induced ototoxicity, offering a foundation for expanded investigation into therapeutic approaches for auditory protection.

14 January 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
RLRongkang Li
Rongkang Li
CLChong Lu
Chong Lu
WYWeiqiang Yang
Weiqiang Yang
YZYaqi Zhou
Yaqi Zhou
JZJiatao Zhong
Jiatao Zhong
YLYongqing Lai
Yongqing Lai
Background: Nasopharyngeal carcinoma is cancer with unique epidemiological characteristics, showing obvious ethnicity, gender, and geographical prevalence. More and more evidence shows that microRNAs are stable in serum and are specific to different tumor types. Therefore, miRNA is a new non‐invasive biomarker for cancer detection.Methods: The experiment is divided into three stages, namely, the screening stage, the training stage, and the verification stage. We took 54 patients with nasopharyngeal carcinoma and 108 healthy controls as the research objects. We use the receiver‐operating characteristic (ROC) curve and area under the ROC curve (AUC) to evaluate the diagnostic value of miRNA. Finally, a three‐miRNA panel with high diagnostic efficiency was constructed. In addition, we conducted biological information analysis of these miRNAs to explore their functions.Results: In NPC patients, the expression of five serum miRNAs (miR‐29c‐3p, miR‐143‐5p, miR‐150‐5p, miR‐145‐3p, and miR‐205‐5p) is significantly dysregulated. Among them, the diagnostic value of these three miRNAs (miR‐29c‐3p, AUC = 0.702; miR‐143‐5p, AUC = 0.733; and miR‐205‐5p, AUC = 787) is more prominent. The diagnostic panel constructed by them has a higher diagnostic value (AUC = 0.902). Through the analysis of the TCGA data set, the target gene of the three‐miRNA panel may be KLF7, NRG1, SH3BGRL2, and SYNPO2.Conclusion: The three‐miRNA panel (miR‐29c‐3p, miR‐143‐5p, and miR‐205‐5p) may become a novel non‐invasive biological marker for nasopharyngeal cancer screening.

22 April 2021 in Neural Plasticity
Verified
Journal Article
Open access
PDF file
XMXueshuang Mei
Xueshuang Mei
YZYaqi Zhou
Yaqi Zhou
MAMuhammad Amjad
Muhammad Amjad
WYWeiqiang Yang
Weiqiang Yang
RZRufei Zhu
Rufei Zhu
HHHongyi Hu
Hongyi Hu
Background. Approximately 70% of congenital deafness is attributable to genetic causes. Incidence of congenital deafness is known to be higher in families with consanguineous marriage. In this study, we investigated the genetic causes in three consanguineous Pakistani families segregating with prelingual, severe-to-profound deafness. Results. Through targeted next-generation sequencing of 414 genes known to be associated with deafness, homozygous variants c.536del (p. Leu180Serfs20) in TECTA, c.3719 G>A (p. Arg1240Gln) in MYO7A, and c.482+1986_1988del in HGF were identified as the pathogenic causes of enrolled families. Interestingly, in one large consanguineous family, an additional c.706G>A (p. Glu236Lys) variant in the X-linked POU3F4 gene was also identified in multiple affected family members causing deafness. Genotype-phenotype cosegregation was confirmed in all participating family members by Sanger sequencing. Conclusions. Our results showed that the genetic causes of deafness are highly heterogeneous. Even within a single family, the affected members with apparently indistinguishable clinical phenotypes may have different pathogenic variants.

25 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YZYaqi Zhou
Yaqi Zhou
WYWeiqiang Yang
Weiqiang Yang
XMXueshuang Mei
Xueshuang Mei
HHHongyi Hu
Hongyi Hu
Background. Nasopharyngeal carcinoma (NPC) is a rare but highly aggressive tumor that is predominantly encountered in Southeast Asia and China in particular. Aside from radiotherapy, no effective therapy that specifically treats NPC is available, including targeted drugs. Finding more sensitive biomarkers is important for new drug discovery and for evaluating patient prognosis. Methods. mRNA expression datasets from the Gene Expression Omnibus database (GSE53819, GSE64634, and GSE40290) were selected. After all samples in each dataset were subjected to quality control using principal component analyses, the qualified samples were used for additional analyses. The genes that were significantly expressed in each dataset were intersected to identify the most significant of these. Gene functional enrichment analyses were performed on these genes, using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes analyses. The protein–protein interaction network of selected genes was analyzed using the Search Tool for the Retrieval of Interacting Genes database. Significantly, differentially expressed genes were further verified with two RNA‐seq datasets (GSE68799 and GSE12452), as well as in clinical samples. Results. In all, 34 (8 upregulated genes and 26 downregulated) genes were identified as significantly differentially expressed. The immune response and the regulation of cell proliferation were the most enriched biological GO terms. Using reverse transcription quantitative real‐time PCR (RT‐qPCR), the genes MMP1, AQP9, and TNFAIP6 were detected to be upregulated, and FAM3D, CR2, and LTF were downregulated in NPC tissue samples. Conclusion. This study provides information on the genes that may be involved in the development of NPC and suggests possible druggable targets and biomarkers for diagnosing and evaluating the prognosis of NPC.